查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1672688

全球兽医肿瘤市场：按动物类型、按治疗类型、按剂型、按应用、按分销管道、按地区

Veterinary Oncology Market, By Animal Type, By Therapy Type, By Mode of Administration, By Application, By Distribution Channel, By Geography
出版日期: | 出版商: Coherent Market Insights | 英文 225 Pages | 商品交期: 2-3个工作天内

价格
简介目录

2025 年全球兽医肿瘤市场规模估计为 8.105 亿美元，预计到 2032 年将达到 17.706 亿美元，2025 年至 2032 年的复合年增长率为 11.8%。

报告范围 报告详细信息
基准年 2024 2025 年市场规模 8.105亿美元
效能资料 2020-2024 预测期 2025-2032
预测期：2025-2032年复合年增长率： 11.80％ 2032 年价值预测 17.706 亿美元
数字。 2025 年兽医肿瘤学市场份额（按地区划分）
兽医肿瘤市场-IMG1

由于动物保健支出的增加和宠物拥有量的增加，兽医肿瘤市场正在经历显着的增长。人类与动物之间关係的加深以及对宠物癌症认识的不断提高，推动了对兽医肿瘤学先进诊断方法和治疗程序的需求。此外，狗和猫中淋巴瘤、乳腺肿瘤、口腔黑色素瘤和肥大细胞瘤等癌症的发生率不断增加，也增加了对有效治疗方案和早期检测的需求。兽医肿瘤学家和肿瘤学专家的数量不断增加，以及开发创新配方的持续研究，进一步推动了全球市场的扩张。然而，癌症治疗和诊断程序的高昂费用仍然是一个巨大的挑战。

市场动态：

全球兽医肿瘤市场的成长受到宠物癌症发生率上升、宠物保险采用率增加、兽医保健支出增加和技术进步的推动。统计数据显示，10岁以上的狗中超过50%会罹患癌症，其中淋巴瘤是狗中最常见的血癌。快速的都市化、核心家庭和日益增强的孤独感正在推高全球的宠物拥有率。这使得宠物饲主更加关注宠物的健康，并在优质治疗上花费更多。各种组织都在资金支持与兽医肿瘤学相关的临床试验和研究活动，这对市场成长起着至关重要的作用。然而，预测期内肿瘤药物、诊断测试和手术的高成本以及新兴经济体缺乏认知预计将阻碍市场扩张。透过社群媒体宣传活动和会议持续传播有关宠物癌症的认识，预计将为市场的主要企业提供大量有利可图的机会。

本研究的主要特点

  • 本报告对全球兽医肿瘤市场进行了详细分析，并以 2024 年为基准年，展示了预测期（2025-2032 年）的市场规模和复合年增长率。
  • 它还强调了各个领域的潜在收益成长机会，并说明了该市场的引人注目的投资提案矩阵。
  • 它还提供了对市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景以及主要企业采用的竞争策略的重要见解。
  • 它根据公司亮点、产品系列、关键亮点、财务表现和策略等参数，概述了全球兽医肿瘤学市场的主要企业。
  • 主要公司包括 Zoetis Inc.、Elanco、AB Science、Boehringer Ingelheim International GmbH、Zenoaq、VetDC、Morphogenesis, Inc.、Karyopharm Therapeutics, Inc.、Regeneus Ltd.、AdvaVet, Inc.、Rhizen Pharmaceutical SA.、PetCure Oncology Ltd
  • 本报告的见解可以帮助负责人和企业经营团队就未来的产品发布、类型升级、市场扩张和行销策略做出明智的决策。
  • 全球兽医肿瘤学市场迎合了该行业的各种相关人员，例如投资者、供应商、产品製造商、经销商、新进业者和金融分析师。
  • 相关人员可以透过用于分析全球兽医肿瘤学市场的各种策略矩阵更轻鬆地做出决策。

目录

第一章 调查目的与前提条件

  • 研究目标
  • 先决条件
  • 简称

第二章 市场展望

  • 报告描述
    • 市场定义和范围
  • 执行摘要
  • Coherent Opportunity Map（COM）

第三章市场动态、法规与趋势分析

  • 市场动态
    • 驱动程式
    • 限制因素
    • 机会
  • 影响分析
  • 流行病学
  • 市场趋势
  • 主要进展
  • 监管情景
  • 收购和合作场景
  • 资金筹措和投资
  • PEST分析
  • 波特的分析

第 4 章。全球兽医肿瘤学市场：COVID-19 大流行的影响

  • 整体影响
  • 政府倡议
  • COVID-19 市场影响

5. 全球兽医肿瘤市场按动物类型划分（2020-2032 年）

  • 宠物
  • 马
  • 犬科动物
  • 猫科
  • 家畜

6. 全球兽医肿瘤市场依治疗类型划分（2020-2032 年）

  • 化疗
  • 联合治疗
  • 免疫疗法
  • 标靶治疗

7. 全球兽医肿瘤市场依剂型划分（2020-2032 年）

  • 口服
  • 静脉

8. 全球兽医肿瘤学市场按应用划分（2020-2032 年）

  • 犬淋巴瘤
  • 骨癌(OSA)
  • 肥大细胞癌
  • 恶性黑色素瘤
  • 其他的

9. 全球兽医肿瘤市场依通路划分（2020-2032 年）

  • 院内药房
  • 政府
  • 零售药局

第 10 章。全球兽医肿瘤市场按地区划分（2020-2032 年）

  • 北美洲
  • 拉丁美洲
  • 欧洲
  • 亚太地区
  • 中东
  • 非洲

第十一章 竞争格局

  • 公司简介
    • Zoetis Inc.
    • Elanco
    • AB Science
    • Boehringer Ingelheim International GmbH
    • Zenoaq
    • VetDC
    • Morphogenesis, Inc.
    • Karyopharm Therapeutics, Inc.
    • Regeneus Ltd.
    • AdvaVet, Inc.
    • Rhizen Pharmaceutical SA.
    • PetCure Oncology
    • Varian Medical Systems
    • Accuray Incorporated
    • One Health
    • Regeneus Ltd.

第 12 章分析师建议

  • 命运之轮
  • 分析师观点
  • Coherent Opportunity Map（COM）

第十三章参考文献与调查方法

  • 参考
  • 调查方法
简介目录
Product Code: CMI2995

Global Veterinary Oncology Market is estimated to be valued at USD 810.5 Mn in 2025 and is expected to reach USD 1,770.6 Mn by 2032, growing at a compound annual growth rate (CAGR) of 11.8% from 2025 to 2032.

Report Coverage Report Details
Base Year: 2024 Market Size in 2025: USD 810.5 Mn
Historical Data for: 2020 To 2024 Forecast Period: 2025 To 2032
Forecast Period 2025 to 2032 CAGR: 11.80% 2032 Value Projection: USD 1,770.6 Mn
Figure. Veterinary Oncology Market Share (%), By Region 2025
Veterinary Oncology Market - IMG1

The veterinary oncology market is experiencing significant growth due to rising animal healthcare expenditure and increasing pet ownership. Growing human-animal bonds and rising awareness about cancer in companion animals are propelling demand for advanced diagnostic methods and therapeutic procedures for veterinary oncology. Moreover, increasing incidence of cancers such as lymphoma, mammary tumor, oral melanoma, and mast cell tumors in dogs and cats is driving the need for effective treatment options and early detection. Growing number of veterinary oncologists and oncology specialists along with ongoing research for developing innovative drug formulations are further supporting market expansion on a global level. However, high costs associated with cancer therapies and diagnostic procedures remain a major challenge.

Market Dynamics:

The global veterinary oncology market growth is driven by rising incidence of cancer in companion animals, increase in pet insurance purchases, growing animal health expenditure, and technological advancements. According to statistics, over 50% of dogs over the age of 10 will develop cancer and lymphoma is the most common blood cancer in dogs. Rapid urbanization accompanied with rising nuclear families and increasing loneliness levels have boosted pet adoption rates globally. This has led to pet owners becoming more aware regarding the health of their pets and willing to spend more on premium treatments. Various organizations are financially supporting clinical trials and research activities related to veterinary oncology which is playing a significant role in market growth. However, high costs associated with oncology medications, diagnostic tests, surgeries, and lack of awareness in developing nations are anticipated to hamper the market expansion during the forecast period. Ongoing initiatives to spread awareness regarding cancer in pets through social media campaigns and conferences are expected to bring numerous lucrative opportunities for key players in the market.

Key Features of the Study:

  • This report provides an in-depth analysis of the global veterinary oncology market, and provides market size (USD Mn) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year
  • It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global veterinary oncology market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this includes Zoetis Inc., Elanco, AB Science, Boehringer Ingelheim International GmbH, Zenoaq, VetDC, Morphogenesis, Inc., Karyopharm Therapeutics, Inc., Regeneus Ltd., AdvaVet, Inc., Rhizen Pharmaceutical SA., PetCure Oncology, Varian Medical Systems, Accuray Incorporated, One Health, and Regeneus Ltd.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • Global veterinary oncology market caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global veterinary oncology market

Detailed Segmentation-

  • By Animal Type:
    • Companion Animal
    • Equine
    • Canine
    • Feline
    • Livestock Animal
  • By Therapy Type:
    • Chemotherapy
    • Combination Therapy
    • Immunotherapy
    • Targeted Therapy
  • By Mode of Administration:
    • Oral
    • Intravenous
  • By Application:
    • Canine Lymphoma
    • Osteosarcoma (OSA)
    • Mast Cell Cancer
    • Melanoma
    • Others
  • By Distribution Channel:
    • Hospital Pharmacies
    • Government Agencies
    • Retail Pharmacies
  • By Region:
    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East
    • Africa
  • Company Profiles:
    • Zoetis Inc.
    • Elanco
    • AB Science
    • Boehringer Ingelheim International GmbH
    • Zenoaq
    • VetDC
    • Morphogenesis, Inc.
    • Karyopharm Therapeutics, Inc.
    • Regeneus Ltd.
    • AdvaVet, Inc.
    • Rhizen Pharmaceutical SA.
    • PetCure Oncology
    • Varian Medical Systems
    • Accuray Incorporated
    • One Health
    • Regeneus Ltd.

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snapshot, By Animal Type
    • Market Snapshot, By Therapy Type
    • Market Snapshot, By Mode of Administration
    • Market Snapshot, By Application
    • Market Snapshot, By Distribution Channel
    • Market Snapshot, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Opportunities
  • Impact Analysis
  • Epidemiology
  • Market Trends
  • Key Developments
  • Regulatory Scenario
  • Acquisitions and Partnerships Scenario
  • Funding and Investments
  • PEST Analysis
  • Porter's Analysis

4. Global Veterinary Oncology Market - Impact of Coronavirus (COVID-19) Pandemic

  • Overall Impact
  • Government Initiatives
  • COVID-19 Impact on the Market

5. Global Veterinary Oncology Market, By Animal Type, 2020 - 2032, (USD Mn)

  • Overview
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Companion Animal
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
  • Equine
  • Canine
  • Feline
  • Livestock Animal
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)

6. Global Veterinary Oncology Market, By Therapy Type, 2020 - 2032, (USD Mn)

  • Overview
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Chemotherapy
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
  • Combination Therapy
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
  • Immunotherapy
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
  • Targeted Therapy
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)

7. Global Veterinary Oncology Market, By Mode of Administration, 2020 - 2032, (USD Mn)

  • Overview
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Oral
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
  • Intravenous
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)

8. Global Veterinary Oncology Market, By Application, 2020 - 2032, (USD Mn)

  • Overview
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Canine Lymphoma
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
  • Osteosarcoma (OSA)
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
  • Mast Cell Cancer
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
  • Melanoma
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
  • Others
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)

9. Global Veterinary Oncology Market, By Distribution Channel, 2020 - 2032, (USD Mn)

  • Overview
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Hospital Pharmacies
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
  • Government Agencies
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
  • Retail Pharmacies
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)

10. Global Veterinary Oncology Market, By Region, 2020 - 2032, (USD Mn)

  • Introduction
    • Market Share Analysis, By Region, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, For Region, 2021-2032
    • Regional Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Animal Type, 2020 - 2032, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2020 - 2032, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Mode of Administration, 2020 - 2032, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Mn)
      • U.S.
      • Canada
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Animal Type, 2020 - 2032, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2020 - 2032, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Mode of Administration, 2020 - 2032, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Mn)
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Animal Type, 2020 - 2032, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2020 - 2032, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Mode of Administration, 2020 - 2032, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Mn)
      • U.K.
      • Germany
      • Italy
      • France
      • Spain
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Animal Type, 2020 - 2032, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2020 - 2032, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Mode of Administration, 2020 - 2032, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Mn)
      • China
      • India
      • Japan
      • ASEAN
      • Australia
      • South Korea
      • Rest of Asia Pacific
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Animal Type, 2020 - 2032, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2020 - 2032, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Mode of Administration, 2020 - 2032, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Mn)
      • GCC
      • Israel
      • Rest of Middle East
  • Africa
      • North Africa
      • Central Africa
      • South Africa

11. Competitive Landscape

  • Company Profiles
    • Zoetis Inc.*
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Elanco
    • AB Science
    • Boehringer Ingelheim International GmbH
    • Zenoaq
    • VetDC
    • Morphogenesis, Inc.
    • Karyopharm Therapeutics, Inc.
    • Regeneus Ltd.
    • AdvaVet, Inc.
    • Rhizen Pharmaceutical SA.
    • PetCure Oncology
    • Varian Medical Systems
    • Accuray Incorporated
    • One Health
    • Regeneus Ltd.

12. Analyst Recommendations

  • Wheel of Fortune
  • Analyst View
  • Coherent Opportunity Map

13. References and Research Methodology

  • References
  • Research Methodology
  • About us and Sales Contact